<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>During disease progression in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), clonal blasts gain a more aggressive nature, whereas nonclonal immune cells become less efficient via an unknown mechanism </plain></SENT>
<SENT sid="1" pm="."><plain>Using <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cell lines and patient samples, we showed that the expression of an immunoinhibitory molecule, B7-H1 (CD274), was induced by interferon-gamma (IFNgamma) and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNFalpha) on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> blasts </plain></SENT>
<SENT sid="2" pm="."><plain>This induction was associated with the activation of nuclear factor-kappaB (NF-kappaB) and nearly completely blocked by an NF-kappaB inhibitor, <z:chebi fb="0" ids="33135">pyrrolidine</z:chebi> dithiocarbamate (PDTC) </plain></SENT>
<SENT sid="3" pm="."><plain>B7-H1(+) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> blasts had greater intrinsic proliferative capacity than B7-H1(-) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> blasts when examined in various assays </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, B7-H1(+) blasts suppressed T-cell proliferation and induced T-cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in allogeneic cocultures </plain></SENT>
<SENT sid="5" pm="."><plain>When fresh bone marrow samples from patients were examined, blasts from high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients expressed B7-H1 molecules more often compared with those from low-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> T cells often overexpressed programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> 1 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1) molecules that transmit an inhibitory signal from B7-H1 molecules </plain></SENT>
<SENT sid="7" pm="."><plain>Taken together, these findings provide new insight into <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> pathophysiology </plain></SENT>
<SENT sid="8" pm="."><plain>IFNgamma and TNFalpha activate NF-kappaB that in turn induces B7-H1 expression on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> blasts </plain></SENT>
<SENT sid="9" pm="."><plain>B7-H1(+) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> blasts have an intrinsic proliferative advantage and induce T-cell suppression, which may be associated with disease progression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>